Prime, shock and kill: BCL-2 inhibition for HIV cure
While modern HIV therapy can effectively suppress viral replication, the persistence of the latent reservoir posits the greatest hurdle to complete cure. The “shock and kill” strategy is under investigation for HIV therapy, aiming to reactivate latent HIV, and subsequently eliminate it through anti-...
Main Authors: | Aswath P. Chandrasekar, Andrew D. Badley |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033609/full |
Similar Items
-
Dynamic modulation of the non-canonical NF-κB signaling pathway for HIV shock and kill
by: Aswath P. Chandrasekar, et al.
Published: (2024-03-01) -
HIV Reservoirs and Treatment Strategies toward Curing HIV Infection
by: Kouki Matsuda, et al.
Published: (2024-02-01) -
New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
by: Katherine M. Bricker, et al.
Published: (2021-08-01) -
Latency Reversing Agents: Kick and Kill of HTLV-1?
by: Annika P. Schnell, et al.
Published: (2021-05-01) -
Compounds producing an effective combinatorial regimen for disruption of HIV‐1 latency
by: Pargol Hashemi, et al.
Published: (2018-02-01)